Terpenes and Testing: The Podcast with Austin Stevenson (EP17)
On this episode, Dr. Lupoi speaks with Austin Stevenson, chief innovation officer of Vertosa. The conversation revolves around Vertosa’s beverage formulation work for companies like Lagunitas and Pabst Blue Ribbon, the importance of brand recognition for some demographics new to the cannabis industry, the future of cannabis beverages, and the basics of making a nanoemulsion.
Terpenes and Testing: The Podcast with Nigam Arora (EP16)
On this episode, Dr. Lupoi speaks with Dr. Nigam Arora, co-founder of the boutique consulting firm Marcu & Arora. Their conversation regards both cannabis & psychedelics, with discussion points including the Pennsylvania product recall, how we can best educate non-scientists on cannabis and psychedelics science and medicine, and whether psychedelic molecules really have the power to change humankind quickly and for the betterment of the planet.
Terpenes and Testing: The Podcast with Dr. Jeff Raber (EP15)
On this episode, Dr. Lupoi chats with Dr. Jeff Raber of The Werc Shop. Dr. Raber provides an excellent discourse on how he got involved in cannabis, how The Werc Shop evolved from a cannabis testing lab to become a leading product design/formulation company, how a product is designed and standardized, and what problems may exist when scaling a novel formulation.
Terpenes and Testing: The Podcast with John Roelke (EP14)
On this episode, Dr. Lupoi speaks with John Roelke, Brand Ambassador for Extracts Consultants. The conversation revolves around the importance of terpenes in not only cannabis formulations, but increasingly so in beer and other spirits. John discusses some of the burgeoning products being designed by Extract Consultants, how his clients have traditionally utilized terpene formulations, and what his favorite terpenes are and why.
Terpenes and Testing: The Podcast with Bryant Jones (EP13)
On this episode, Dr. Lupoi speaks with Bryant Jones, an herbalist out of the University of Minnesota. Their conversation regards the specifics on how degrees based in herbalism differ from horticulture or botany, Bryant’s main goals as a cultivator in the cannabis industry and where he sees some farmers going wrong, as well as his advice to smaller grows looking to survive in an industry increasingly being dominated by corporate cultivators.
Terpenes and Testing: The Podcast with Brad Douglass, Ph.D. (EP12)
On this episode, Dr. Lupoi speaks with Dr. Brad Douglass of The Werc Shop and Spoke Sciences, Inc. Dr. Douglass provides a commentary on the safety of flavor additives in cannabis products as well as on GRAS substances, postulates the idea for a defined prohibited and permitted ingredient list such as the list for additives in cigarettes, and weighs in on the synthetic cannabinoid craze. Drs Lupoi and Douglass also delve into the Pennsylvania product recall (which has since been reversed!).
Terpenes and Testing: The Podcast with Kevin Koby (EP11)
On this episode, Dr. Lupoi speaks with Kevin Koby of ABSTRAX about how Kevin got involved in the cannabis industry, why ABSTRAX has chosen to focus on terpenes, how they have utilized two-dimensional gas chromatography to identify molecules comprising a specific cultivar’s essential oil, how this data has served to recreate a given cultivar’s terpene profile, and the recent publication that ABSTRAX collaborated on that delved into the volatile sulfur compounds in cannabis.
Terpenes and Testing: The Podcast with Andrea Small-Howard, Ph.D. (EP10)
In this episode, Dr. Lupoi speaks with Dr. Andrea Small-Howard of GB Sciences regarding the work GB Sciences is doing to prove the entourage effect between cannabinoids and cannabinoids, cannabinoids, and terpenes, and even terpenes and terpenes. Drs. Lupoi and Small-Howard also delve into GB Sciences’ novel formulations for treating Parkinson’s disease and coronaviruses.
The Terpenes and Testing Podcast with Patrick Nightingale, Esq. (EP9)
On this episode, Dr. Lupoi engages in a lively chat with attorney Patrick Nightingale, Executive Director of the Pennsylvania Medical Cannabis Society and Partner at Cannabis Legal Solutions. Discussion points include how Nightingale got involved in cannabis law, the erroneous (and ridiculous) labeling of cannabis as schedule I, the sad, maddening reality that cannabis and psilocybin are still schedule I while Xanax, Fentanyl, and OxyContin are schedules II and IV, and Pennsylvania Senate Bill 749 and the lack of any legal definition of cannabis impairment.
The Terpenes and Testing Podcast with Ethan Russo (EP8)
On this episode, Dr. Lupoi chats with the esteemed board-certified neurologist, psychopharmacology researcher, and author Dr. Ethan Russo. Discussion points include the endocannabinoid system (ECS) and our bodies seeming almost mechanized to utilize cannabinoids, whether a medical doctor can properly treat us without knowledge on the ECS, Dr. Russo’s travels to South America in search of ethnobotanical plants, and a candid discourse on synthetic cannabinoids like delta-8-THC, THCP, and HHC.
The Terpenes and Testing Podcast with Michael Backes (EP7)
On this episode, Dr. Lupoi chats with Michael Backes, co-founder and chief product officer of the cannabis company Perfect. Backes is also the author of Cannabis Pharmacy. Discussion points include Backes’ research for his book, how harvesting, drying, and curing diminish peak terpene concentrations, Perfect’s cold-infusion process, what “too much terpenes” might look like, and the poetically karmic Perfect creation called the 2 in 1 Perfecto, a joint meant to be shared!
The Terpenes and Testing Podcast with Dr. Michelle Ross (EP6)
On this episode, Dr. Lupoi chats with neuroscientist Dr. Michelle Ross. Discussion points include Dr. Ross’s advocacy of cannabis for treating chronic pain, truths and fallacies regarding cannabis & motherhood, and the medicinal uses of kratom, another taboo, ethnobotanical plant with considerable therapeutic promise.
The Terpenes and Testing Podcast with Karla Avila (EP5)
On this episode, Jason S. Lupoi, Ph.D. chats with multi-Emerald Cup award-winning cannabis farmer and breeder, Karla Avila, who co-founded Flowerdaze Farm with her husband. Discussion topics include regenerative farming, terroir (aka “taste the place”), cultivating companion plants, maximizing scarce water resources, and creating a living, thriving ecosystem on your farm.
Terpenes and Testing: The Podcast with Derek Chase (EP4)
In this episode, Jason S. Lupoi, Ph.D. chats with Derek Chase, president of Flora + Bast Cannabis and founder of Psilouette Wellbeing. Discussion points include the stoned ape theory and the idea that psilocybin may have birthed language; why we are pointed towards addictive things like caffeine, TV, and sugar, whereas substances like cannabis and psilocybin are still scheduled I; mushrooms and end-of-life care; and the importance of optimizing one’s set and setting for a psychedelic experience.
Terpenes and Testing: The Podcast with Robert Strongin, Ph D (EP3)
On this episode, Jason S. Lupoi, Ph.D. chats with Robert Strongin, Ph.D., Professor of Organic Chemistry at Portland State University. Drs. Lupoi and Strongin discuss toxicants that can form as terpene degradation products when dabbing at high temperatures, how the levels of these toxicants compare to those formed from smoking a joint, breathing nanoparticles, and the divergent results Dr. Strongin’s group measured between dabbing and vaping higher levels of the monoterpene myrcene.
Terpenes and Testing: The Podcast with Steve Scheier (EP2)
On this episode, Jason S. Lupoi, Ph.D. chats with Steve Scheier, “leadership cultivator” and co-author of the book Power Up: Power Tools for Committed Cannabusiness Leaders. Discussion points include how to effectively find your inner power to help facilitate stepping into a leadership role within the cannabis industry, challenges new managers can face, why your employees should not be your friends, and what effective and ineffective power-wielding strategies look like.
Terpenes and Testing: The Podcast with Dr Bryan Doner (EP1)
In our inaugural podcast episode, T&T editor-in-chief, Jason S. Lupoi, Ph.D., chats with Dr. Bryan Doner, President/CEO of D&P Medical Group. Drs. Doner and Lupoi discuss the endocannabinoid system and its omission in the modern medical school curriculum, Dr. Doner’s personal interest in cannabis-based medicine, and the reaction of some of Dr. Doner’s peers when he became outspoken about cannabis.